argenx (NasdaqGS:ARGX) Update / briefing June 23, 2026 02:00 PM ET Speaker14 Please welcome Beth DelGiacco. Speaker6 Hi, welcome to our Boston Innovation Hub. It's looking very transformed today. Welcome to our second R&D spotlight event. Today, we're going to focus on autoimmune myositis and the opportunity for VYVGART to have a meaningful impact on patients' lives. We have a full house today. We have many investors and analysts. We also have our argenx colleagues here, and during that mix and mingle, we e ...